Does heart rate influence CMR image quality of the coronary vessel wall? by van der Wall, E. E. et al.
EDITORIAL COMMENT
Does heart rate inﬂuence CMR image quality
of the coronary vessel wall?
E. E. van der Wall • E. J. S. Kro ¨ner •
H. M. Siebelink • A. J. Scholte • M. J. Schalij
Received: 13 April 2011/Accepted: 3 May 2011/Published online: 19 May 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Cardiovascular magnetic resonance (CMR) has made
tremendous advances over the past years, providing
accurate evaluation of left ventricular mass, volumes
and function [1–4]. CMR has shown unique abilities
in characterizing myocardial tissue composition. In
particular, high-resolution contrast-enhanced CMR
has been used to visualize myocardial ﬁbrosis with a
high accuracy [5–7]. For instance, in patients with
acute myocardial infarction, the injured myocardium
shows increased CMR contrast compared to normal
myocardium when imaged by delayed gadolinium
enhancement. The transmural extent of delayed
gadolinium enhancement predicts functional outcome
after interventional procedures performed in patients
with acute myocardial infarction and chronic ischemic
heart disease [8–10]. Not only in the setting of an
acute myocardial infarction, but also in patients with
various manifestations of cardiomyopathy, evidence
of delayed gadolinium enhancement may have impor-
tant clinical and prognostic implications [11–13].
CMR has become the ﬁrst choice imaging modality in
complex congenital heart disease and imaging great
vessels [14–18]. Magnetic resonance angiography
(MRA) has been introduced as a method that can
provide visualization of all three major coronary
arteries, coronary bypasses and the aorta within a
single three-dimensional acquisition [19–22]. In par-
ticular, CMR has proven to be of indispensable value
in identifying aortic stiffness in Marfan patients using
pulse wave velocity measurements [23, 24].
A rather new aspect of CMR is coronary vessel
wall imaging. In a study by Macedo et al. [25], 88
arterial segments in 38 asymptomatic participants of
the Multi-Ethnic Study of Atherosclerosis (MESA)
study were evaluated using black blood CMR. CMR-
assessed coronary wall thickness was compared with
computed tomography calcium score, carotid intima-
media thickness, and risk factors for coronary artery
disease. Coronary artery wall CMR detected
increased coronary wall thickness in asymptomatic
individuals with subclinical markers of atheroscle-
rotic disease and in individuals with zero calcium
score. Gerretsen et al. [26] showed that both in
patients with angiographically proven coronary artery
disease and age-matched asymptomatic subjects,
coronary vessel wall thickening was detectable with
CMR coronary vessel wall imaging. Maximum and
mean wall thicknesses were signiﬁcantly higher in the
patient population. The vast majority of asymptom-
atic subjects had either positive remodeling without
luminal narrowing, or non-signiﬁcant stenoses. Kelle
et al. [27] demonstrated coronary artery vessel wall
enhancement using 3.0 Tesla CMR imaging after a
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patients with coronary artery disease, but not in
healthy subjects. In the majority of the evaluated
coronary segments in the patient group, late contrast
enhancement of the coronary vessel wall was already
detectable 30–45 min after administration of the
contrast agent. Recently, Scott et al. [28] showed
that high-resolution thee-dimensional spiral imag-
ing with beat-to-beat respiratory-motion-correction
allowedcoronaryvesselwallassessmentovermultiple
thin contiguous slices in a clinically feasible duration.
Excellent reproducibility of the technique potentially
enables studies of disease progression or regression.
In the current issue of the International Journal of
Cardiovascular Imaging, Lin et al. [29] interestingly
hypothesized that black blood steady-state free pre-
cession (SSFP) would provide coronary wall images
comparable to images from turbo spin-echo imaging
(TSE) and would better perform than TSE under
conditions of increased heart rates. The aim of the
studywastoprospectivelyevaluateatwo-dimensional
double inversion recovery (DIR) prepared SSFP CMR
imaging sequence for black blood coronary wall
imaging and to estimate its value in the detection of
coronary artery disease. The authors investigated 30
healthy volunteers (19 men, 11 women, from 26 to
83 years old) using a 1.5 Tesla CMR scanner. Cross-
sectional black-blood images of the proximal portions
of coronary arteries were acquired with a two-dimen-
sional, double inversion recovery prepared TSE
sequence and a two-dimensional double inversion
recovery SSFP sequence on the same planes. Image
quality, vessel wall area and thickness, signal-to-noise
ratio of the wall and contrast-to-noise ratio (wall to
lumen) were compared between SSFP and TSE with
SPSS software. For SSFP and TSE no differences in
image quality were observed. SSFP had a higher
signal-to-noise ratio and wall to lumen contrast-to-
noise. Good agreements between measured wall area
and thickness were found. For 10 individuals with
heart rates over 80 beats per minute, the image quality
of SSFP was signiﬁcantly better than TSE. With its
higher performance under fast heart rate conditions,
SSFP allows higher thresholds for heart rate and
extends therefore the clinical applicability of coronary
wall MR imaging to more patient populations.
The study suffers from several limitations (also
recognized by the authors). First, the thickness of the
coronary wall may have been overestimated due to
the limited spatial resolution of coronary wall MR
imaging. In this respect, a gold standard such as
IVUS should have used to verify the true thickness of
the wall. Second, there were only 10 (33%) individ-
uals with a heart rate over 80 beats per minute.
Therefore, image quality rather than accuracy could
be established. Third it should be realized that many
physical and physiological parameters could have
affected image quality in coronary wall CMR imag-
ing. These parameters should be taken into account
for upcoming studies. Fourth, only healthy volunteers
were studied, precluding a valid extrapolation of the
ﬁndings to patients with atherosclerotic vessel walls.
In summary, Lin et al. [29] successfully evaluated
two coronary MR techniques (SSFP vs. TSE) in an
asymptomatic healthy population with increased heart
rates.ItturnedoutthatSSFPperformedbetterthanTSE
under conditions of fast heart rate, opening avenues
for studying more and different patient populations. In
the near future, these important ﬁndings have to be
conﬁrmed in patients with coronary artery disease.
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